Clinician warns of potential AI “collusion” with unreliable human input in mental health
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-May-2026 08:15 ET (31-May-2026 12:15 GMT/UTC)
Traumatic brain injury (TBI) affects millions worldwide, yet effective treatments remain limited. A new review outlines how stem cell-based therapies can promote brain repair by reducing inflammation, supporting neural regeneration, and restoring neural function. It also highlights emerging strategies such as exosome-based therapies and biomaterial scaffolds. While early clinical trials and preclinical findings are encouraging, translating these advances into reliable clinical treatments remains a critical next step.
Artificial intelligence is rapidly changing how biomedical materials are discovered and designed. In a new review published in Science Bulletin, researchers summarize how machine learning and generative AI are helping scientists predict material behaviors such as drug release, biocompatibility, and catalytic activity, and even propose entirely new inorganic materials for biomedical applications. The review highlights emerging applications in drug delivery, cancer therapy, anti-inflammatory treatment, and tissue engineering, while also discussing the challenges that still limit clinical translation.
A research team led by Professor Gao Zexia from Huazhong Agricultural University in China has successfully cultivated grass carp completely lacking intermuscular bones (IBs)—small, sharp skeletal structures that not only pose consumption risks to consumers but also limit processing efficiency. By runx2b gene editing, the team obtained genetically stable F₂ populations of grass carp without IBs. Comprehensive phenotypic analysis revealed no significant differences between IBs-free and the wild-type grass carp in overall skeletal development, bone mineral density, muscle composition or nutritional content. Multi-omics data further demonstrated adaptive remodeling in Calcium Signaling and Muscle Contraction Pathways, indicating normal physiological compensation. This study provides a feasible strategy for improving the fish efficiency of aquaculture breeding and enhancing the supply of high quality fish protein.
The Universitat Jaume I of Castelló and GEA Biotechnology have developed an antifungal aqueous suspension for the prevention of fungal infections in crops and fruit during the pre- and post-harvest stages. The new formulation is aimed at the biotechnology and agricultural sectors, and the partners are seeking collaboration for further development and adaptation to commercial applications.
The technology is based on biodegradable chitosan microcapsules encapsulating anethole, a natural compound with antifungal activity, which improves its stability and enables controlled release on crop and fruit surfaces. According to the research team, led by Carolina Clausell from the Ecophysiology and Biotechnology research group coordinated by Aurelio Gómez Cadenas, the formulation “enhances the antifungal efficacy of natural compounds and offers a more sustainable alternative to conventional synthetic fungicides”.